• 

  CSIR begins Phase II clinical trials of Niclosamide for Covid treatment

  India | June 06, 2021 19:52 IST

  Niclosamide has been extensively used in the past for treating tapeworm infection in adults as well as children. The safety profile of this drug has been tested over time and has been found safe for human consumption at different dose levels, the Council for Scientific and Industrial Research (CSIR) said.

• 

  US eager to involve Indian investigators in clinical trials on COVID-19: Dr Fauci

  World | June 04, 2021 8:48 IST

  Dr. Anthony Fauci on Thursday said the US is eager to involve Indian investigators in global clinical trials to evaluate the safety and efficacy of COVID-19 therapeutics.

• 

  China approves new Covid vaccine for clinical trials

  World | April 11, 2021 13:39 IST

  A new Covid-19 vaccine developed by China's Sinopharm has recently been approved for clinical trials.

• 

  DGCI grants approval for clinical trials for third dose of Covaxin

  India | April 02, 2021 13:03 IST

  The expert panel of India's drug regulator, DCGI, has permitted Bharat Biotech to give the third dose of Covaxin to a few volunteers in its clinical trials of the COVID-19 vaccine.

• 

  COVAXIN: AIIMS seeks volunteers for phase-3 trial; Know how to enroll

  India | December 24, 2020 13:45 IST

  The All India Institute Of Medical Sciences (AIIMS) has invited applications for volunteers, who want to take part in the COVAXIN Phase-3 trial, which was indigenously developed by Bharat Biotech.

• 

  Over 100 experts from friendly nations trained for clinical trials of Indian COVID-19 vaccine

  India | December 17, 2020 7:53 IST

  Over 100 experts from friendly neighbouring nations have so far been trained to strengthen capacities in their countries for facilitating phase-3 clinical trials of Indian COVID-19 vaccine, a senior official of the department of biotechnology said on Wednesday.

• 

  Zydus Cadila gets permission from DCGI for phase-1 clinical trial of novel molecule ZYIL1

  India | December 07, 2020 13:00 IST

  Drug firm Zydus Cadila on Monday said it has received permission from Drugs Controller General of India (DCGI) to initiate phase-1 clinical trial of its novel molecule ZYIL1, indicated for use as an inhibitor for inflammation condition 'NLRP3'.

• 

  COVAXIN: Process for COVID-19 vaccine clinical trials begins at NIMS Hyderabad

  India | July 07, 2020 18:58 IST

  The process of conducting clinical trials for Covaxin, a vaccine candidate for COVID-19, began on Tuesday at the Nizams Institute of Medical Sciences (NIMS) in Hyderabad, a top official of the state-run medical facility said. 

• 

  COVID-19: CSIR institute to conduct clinical trials of antiviral drug Umifenovir

  India | June 19, 2020 13:07 IST

  Umifenovir is mainly used for treatment of influenza and is available in China and Russia, and has recently come into prominence due to its potential use for COVID-19 patients.

• 

  Health Ministry publishes New Drugs and Clinical Trials (Amendment) Rules

  India | June 08, 2020 7:31 IST

  The Union Health Ministry has come up with draft New Drugs and Clinical Trials (Amendment) Rules, inserting provisions for "compassionate use" of any unapproved drug that is in the phase-III clinical trial, either in India or abroad, by importing or indigenous manufacturing. 

• 

  India's Drug Act aiding harmful combination drugs without clinical trials: Study

  India | February 10, 2015 14:06 IST

  New Delhi: A latest study has revealed that India's Drug Act has aided proliferation of harmful combination drugs without any clinical trials and with little medical rationale.Many of such drugs are easily available on retail

Advertisement
• 

  Infosys unveils cloud-based solution for clinical trials

  June 05, 2014 7:08 IST

  Bangalore: India's second largest IT firm Infosys Ltd Wednesday unveiled a cloud-based solution to speed up clinical trials and lower drug development costs."The solution helps life sciences companies to accelerate clinical trials by driving greater

• 

  Post stringent norms, clinical trials in India plummet

  India | April 21, 2013 16:33 IST

  New Delhi, Apr 21: Clinical trials of drugs in India have seen a drastic fall this year after toughened norms were introduced following Supreme Court directives.Not only have the number of trial approvals in the

• 

  16 direct deaths in 2012 due to clinical trials, says Govt

  India | March 04, 2013 19:36 IST

  New Delhi, Mar 4: As many as 436 people died during clinical trials in the country in 2012, of which only 16 were attributed directly to such experiments.“As per available data, the number of serious

• 

  Govt set to notify rules for clinical trials

  India | January 04, 2013 20:40 IST

  New Delhi, Jan  4:  After over 2,242 deaths during clinical drug trials in last five years, the government plans to regulate the $500 million sector by bringing changes in drug laws, to make lapses by

• 

  Clinical trials of untested drugs is creating "havoc": SC

  India | January 03, 2013 15:56 IST

  New Delhi, Jan 3:  The Supreme Court today slammed the Centre for its failure to stop illegal clinical trials of untested drugs by multinational companies, saying the drug trials are creating “havoc” in the country